Mice bearing PTEN/RB1-deficient prostate adenocarcinoma, after undergoing castration or abiraterone treatment of PTEN/P53-deficient prostate adenocarcinoma, show generation of NEPC14. Here, RB1 is linked to prostate adenocarcinoma.